SCHEMBL6983430

SCHEMBL6983430

Nc1nc(N)nc(-c2ccc(NS(=O)(=O)c3ccccc3)cc2)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.61
KMT2A Q03164 8/20 0.57
MEN1 O00255 6/20 0.57
ALDH1A1 P00352 1/20 0.57
PKM P14618 1/20 0.57
IL1RN P18510 1/20 0.56
ERAP1 Q9NZ08 1/20 0.56
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
POLB P06746 2/20 0.53
ADORA3 P0DMS8 1/20 0.53
ADORA2A P29274 1/20 0.53
ADORA2B P29275 1/20 0.53
ADORA1 P30542 1/20 0.53
MAPT P10636 4/20 0.52
HPGD P15428 2/20 0.52
LMNA P02545 2/20 0.52
PTPN2 P17706 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985315 0.85 ATM (0.60) KMT2AMEN1ALDH1A1PKMMAPT
SCHEMBL13167612 0.80 KMT2A (0.80) KEAP1KMT2AMEN1ALDH1A1PKM
SCHEMBL6986320 0.79 TSHR (0.60) ALDH1A1MAPTPTPN2PTPN1PTPN5
SCHEMBL6982568 0.79 ADORA3 (0.62) KMT2AMEN1ALDH1A1CA12CA1
SCHEMBL13480185 0.78 KMT2A (0.77) KEAP1KMT2AMEN1ALDH1A1PKM
Lithium SCHEMBL31041155 0.78 KMT2A (0.77) KEAP1KMT2AMEN1ALDH1A1PKM
SCHEMBL810795 0.78 KMT2A (0.91) KEAP1KMT2AMEN1ALDH1A1PKM
SCHEMBL3081180 0.77 KEAP1 (1.00) KEAP1KMT2AMEN1ALDH1A1PKM
SCHEMBL9001182 0.74 KMT2A (1.00) KEAP1KMT2AMEN1ALDH1A1PKM
SCHEMBL25031372 0.74 KEAP1 (1.00) KEAP1KMT2AMEN1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed